Blueprint Medicines' AYVAKIT leads its revenue growth, while its pipeline targets multiple cancers. Read why BPMC stock is a ...

Here, I outline a proven blueprint to help companies successfully launch digital products across borders. A successful product launch rests on understanding three foundational pillars: the product, ...

NEW YORK, Oct. 29, 2024 /PRNewswire/ -- Blueprint Finance, core developer of the Concrete Network, announces the acquisition of Jet Protocol, a developer of Solana decentralized finance products.

Strategic Blueprint LLC increased its stake in shares of iShares Core MSCI Total International Stock ETF (NASDAQ:IXUS – Free Report) by 6.1% in the 3rd quarter, according to its most recent 13F ...

Blueprint Medicines anticipates approximately $475 million to $480 million in global Ayvakit net product revenues in 2024, an increase from $435 million to $450 million in the previous range.

Arm Holdings (NASDAQ: ARM) is one of the best-performing artificial intelligence (AI) stocks of the last year, trading up 119 ...

The Toro Company (NYSE: TTC) states that its purpose is to "help our customers enrich the beauty, productivity, and ...

マルチプロダクトな開発組織で 「開発生産性」に向き合うために試みたこと / Improving Multi-Product Dev Productivity ...

the FDA approved Blueprint Medicines’ Ayvakit (avapritinib) as the first, only treatment for indolent systemic mastocytosis (ISM). In the third quarter of 2024, Ayvakit reported net product ...

Florida’s immigration crackdown defied doomsday predictions. Small businesses and agriculture adapted, and the state’s ...

While the economics of industrial hemp products look promising for farmers, some Alabama doctors insisted on the importance ...